Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor.
Biological Psychiatry July 1, 1989 S J McClue, C Brazell, S M Stahl
We have assayed several phenylalkylamine and indolealkylamine hallucinogens, as well as structurally similar nonhallucinogens, for their effect on human platelet shape change, a physiological model for the central serotonergic 5-HT2 receptor. The hallucinogenic drugs lysergic acid diethylamide (LSD-25), N,N-dimethyltryptamine (N,N-DMT), 5-methoxy-N,N-dimethyltryptamine (5-MeODMT),...
DOI: 10.1016/0006-3223(89)90042-5 (opens in new tab)
Lysergic acid diethylamide
Brain
Blood platelets
Humans
+4